Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR)
収録刊行物
-
- J. Pharmacol. Exp. Ther.
-
J. Pharmacol. Exp. Ther. 280 1304-1311, 1997